Patents by Inventor John C. Bauer

John C. Bauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9272268
    Abstract: The invention provides a composite catalyst containing a first component and a second component. The first component contains nanosized gold particles. The second component contains nanosized platinum group metals. The composite catalyst is useful for catalyzing the oxidation of carbon monoxide, hydrocarbons, oxides of nitrogen, and other pollutants at low temperatures.
    Type: Grant
    Filed: April 1, 2014
    Date of Patent: March 1, 2016
    Assignee: UT-Battelle, LLC
    Inventors: Todd J. Toops, James E. Parks, III, John C. Bauer
  • Publication number: 20150273444
    Abstract: The invention provides a composite catalyst containing a first component and a second component. The first component contains nanosized gold particles. The second component contains nanosized platinum group metals. The composite catalyst is useful for catalyzing the oxidation of carbon monoxide, hydrocarbons, oxides of nitrogen, and other pollutants at low temperatures.
    Type: Application
    Filed: April 1, 2014
    Publication date: October 1, 2015
    Applicant: UT-Battelle, LLC
    Inventors: Todd J. Toops, James E. Parks, III, John C. Bauer
  • Patent number: 7176004
    Abstract: The invention provides improved methods of introducing site-directed mutations into circular DNA molecules of interest by means of mutagenic primer pairs. The mutagenic primer pairs are also selected so as to be either completely complementary or partially complementary to each other, wherein the mutation site (or sites) is located within the region of complementarity. A mutagenic primer pair is annealed to opposite strands of a circular DNA molecule containing the DNA sequence to be mutagenized. After annealing, first and second mutagenized DNA strands, each incorporating a member of the mutagenic oligonucleotide primer pair is synthesized by a linear cyclic amplification reaction. After the linear cyclic amplification mediated synthesis step is completed, the reaction mixture is treated with a selection enzyme that digests the parental template strands. After the digesting step, a double-stranded circular DNA intermediate is formed.
    Type: Grant
    Filed: March 25, 2004
    Date of Patent: February 13, 2007
    Assignees: Stratagene California, Children's Medical Center Corporation
    Inventors: John C. Bauer, Dowain A. Wright, Jeffrey Carl Braman, Raif S. Geha
  • Patent number: 7132265
    Abstract: The invention provides improved methods of introducing site-directed mutations into circular DNA molecules of interest by means of mutagenic primer pairs. The mutagenic primer pairs are also selected so as to be either completely complementary or partially complementary to each other, wherein the mutation site (or sites) is located within the region of complementarity. A mutagenic primer pair is annealed to opposite strands of a circular DNA molecule containing the DNA sequence to be mutagenized. After annealing, first and second mutagenized DNA strands, each incorporating a member of the mutagenic oligonucleotide primer pair is synthesized by a linear cyclic amplification reaction. After the linear cyclic amplification mediated synthesis step is completed, the reaction mixture is treated with a selection enzyme that digests the parental template strands. After the digesting step, a double-stranded circular DNA intermediate is formed.
    Type: Grant
    Filed: August 26, 2002
    Date of Patent: November 7, 2006
    Assignees: Stratagene California, Children's Medical Center Corporation
    Inventors: John C. Bauer, Dowain A. Wright, Jeffrey Carl Braman, Raif S. Geha
  • Publication number: 20040253729
    Abstract: The invention provides improved methods of introducing site-directed mutations into circular DNA molecules of interest by means of mutagenic primer pairs. The mutagenic primer pairs are also selected so as to be either completely complementary or partially complementary to each other, wherein the mutation site (or sites) is located within the region of complementarity. A mutagenic primer pair is annealed to opposite strands of a circular DNA molecule containing the DNA sequence to be mutagenized. After annealing, first and second mutagenized DNA strands, each incorporating a member of the mutagenic oligonucleotide primer pair is synthesized by a linear cyclic amplification reaction. After the linear cyclic amplification mediated synthesis step is completed, the reaction mixture is treated with a selection enzyme that digests the parental template strands. After the digesting step, a double-stranded circular DNA intermediate is formed.
    Type: Application
    Filed: March 25, 2004
    Publication date: December 16, 2004
    Applicant: Stratagene and Children's Medical Center Corporation
    Inventors: John C. Bauer, Dowain A. Wright, Jeffrey Carl Braman, Raif S. Geha
  • Patent number: 6713285
    Abstract: The invention provides improved methods of introducing site-directed mutations into circular DNA molecules of interest by means of mutagenic primer pairs. The mutagenic primer pairs are also selected so as to be either completely complementary or partially complementary to each other, wherein the mutation site (or sites) is located within the region of complementarity. A mutagenic primer pair is annealed to opposite strands of a circular DNA molecule containing the DNA sequence to be mutagenized. After annealing, first and second mutagenized DNA strands, each incorporating a member of the mutagenic oligonucleotide primer pair is synthesized by a linear cyclic amplification reaction. After the linear cyclic amplification mediated synthesis step is completed, the reaction mixture is treated with a selection enzyme that digests the parental template strands. After the digesting step, a double-stranded circular DNA intermediate is formed.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: March 30, 2004
    Assignees: Stratagene, Children's Medical Center Corporation
    Inventors: John C. Bauer, Dowain A. Wright, Jeffrey Carl Braman, Raif S. Geha
  • Publication number: 20040003890
    Abstract: A system and method for producing interior trim components is described. The system includes producing a substrate material from either metal or reinforced polymer materials. The substrate is then coated with adhesive. The adhesive coated substrate is then covered with a thick film containing artwork or a piece of natural wood veneer, which is applied using a mechanism that utilizes membrane to apply hydrostatic pressure to the thick film or the piece of natural wood veneer over the substrate in the presence of heat.
    Type: Application
    Filed: February 20, 2003
    Publication date: January 8, 2004
    Applicant: Breed Automotive Technology, Inc.
    Inventors: John C. Bauer, Xiaohang Song, Li Zhao
  • Publication number: 20030064516
    Abstract: The invention provides improved methods of introducing site-directed mutations into circular DNA molecules of interest by means of mutagenic primer pairs. The mutagenic primer pairs are also selected so as to be either completely complementary or partially complementary to each other, wherein the mutation site (or sites) is located within the region of complementarity. A mutagenic primer pair is annealed to opposite strands of a circular DNA molecule containing the DNA sequence to be mutagenized. After annealing, first, and second mutagenized DNA strands, each incorporating a member of the mutagenic oligonucleotide primer pair is synthesized by a linear cyclic amplification reaction. After the linear cyclic amplification mediated synthesis step is completed, the reaction mixture is treated with a selection enzyme that digests the parental template strands. After the digesting step, a double-stranded circular DNA intermediate is formed.
    Type: Application
    Filed: August 26, 2002
    Publication date: April 3, 2003
    Applicant: Stratagene and Children's Medical Center Corporation
    Inventors: John C. Bauer, Dowain A. Wright, Jeffrey Carl Braman, Raif S. Geha
  • Publication number: 20030032037
    Abstract: The invention provides improved methods of introducing site-directed mutations into circular DNA molecules of interest by means of mutagenic primer pairs. The mutagenic primer pairs are also selected so as to be either completely complementary or partially complementary to each other, wherein the mutation site (or sites) is located within the region of complementarity. A mutagenic primer pair is annealed to opposite strands of a circular DNA molecule containing the DNA sequence to be mutagenized. After annealing, first and second mutagenized DNA strands, each incorporating a member of the mutagenic oligonucleotide primer pair is synthesized by a linear cyclic amplification reaction. After the linear cyclic amplification mediated synthesis step is completed, the reaction mixture is treated with a selection enzyme that digests the parental template strands. After the digesting step, a double-stranded circular DNA intermediate is formed.
    Type: Application
    Filed: May 10, 2002
    Publication date: February 13, 2003
    Inventors: John C. Bauer, Dowain A. Wright, Jeffrey Carl Braman, Raif S. Geha
  • Patent number: 6391548
    Abstract: The invention provides improved methods of introducing site-directed mutations into circular DNA molecules of interest by means of mutagenic primer pairs. The mutagenic primer pairs are also selected so as to be either completely complementary or partially complementary to each other, wherein the mutation site (or sites) is located within the region of complementarity. A mutagenic primer pair is annealed to opposite strands of a circular DNA molecule containing the DNA sequence to be mutagenized. After annealing, first and second mutagenized DNA strands, each incorporating a member of the mutagenic oligonucleotide primer pair is synthesized by a linear cyclic amplification reaction. After the linear cyclic amplification mediated synthesis step is completed, the reaction mixture is treated with a selection enzyme that digests the parental template strands. After the digesting step, a double-stranded circular DNA intermediate is formed.
    Type: Grant
    Filed: March 23, 1999
    Date of Patent: May 21, 2002
    Assignees: Stratagene, Children's Medical Center Corp.
    Inventors: John C. Bauer, Dowain A. Wright, Jeffrey Carl Braman, Raif S. Geha
  • Patent number: 5932419
    Abstract: The invention provides improved methods of introducing site-directed mutations into circular DNA molecules of interest by means of mutagenic primer pairs. The mutagenic primer pairs are also selected so as to be either completely complementary or partially complementary to each other, wherein the mutation site (or sites) is located within the region of complementarity. A mutagenic primer pair is annealed to opposite strands of a circular DNA molecule containing the DNA sequence to be mutagenized. After annealing, first and second mutagenized DNA strands, each incorporating a member of the mutagenic oligonucleotide primer pair is synthesized by a linear cyclic amplification reaction. After the linear cyclic amplification mediated synthesis step is completed, the reaction mixture is treated with a selection enzyme that digests the parental template strands. After the digesting step, a double-stranded circular DNA intermediate is formed.
    Type: Grant
    Filed: April 17, 1997
    Date of Patent: August 3, 1999
    Assignees: Stratagene, La Jolla, California, Children's Medical Center Corporation
    Inventors: John C. Bauer, Dowain A. Wright, Jeffrey Carl Braman, Raif S. Geha
  • Patent number: 5789166
    Abstract: The invention provides improved methods of introducing site-directed mutations into circular DNA molecules of interest by means of mutagenic primer pairs. The mutagenic primer pairs are also selected so as to be either completely complementary or partially complementary to each other, wherein the mutation site (or sites) is located within the region of complementarity. A mutagenic primer pair is annealed to opposite strands of a circular DNA molecule containing the DNA sequence to be mutagenized. After annealing, first and second mutagenized DNA strands, each incorporating a member of the mutagenic oligonucleotide primer pair is synthesized by a linear cyclic amplification reaction. After the linear cyclic amplification mediated synthesis step is completed, the reaction mixture is treated with a selection enzyme that digests the parental template strands. After the digesting step, a double-stranded circular DNA intermediate is formed.
    Type: Grant
    Filed: December 8, 1995
    Date of Patent: August 4, 1998
    Assignee: Stratagene
    Inventors: John C. Bauer, Dowain A. Wright, Jeffrey Carl Braman, Raif S. Geha